Amanote Research
Register
Sign In
Pcn79 - Decision Impact of a 21-Gene Signature in Early Breast Cancer: A Natural Experiment Using Routine Data
Value in Health
- United Kingdom
doi 10.1016/j.jval.2018.09.161
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
October 1, 2018
Authors
G. Tramonti
E. Gray
A.H. Sims
P.S. Hall
Publisher
Elsevier BV
Related search
Cost-Effectiveness Analysis of Recurrence Score-Guided Treatment Using a 21-Gene Assay in Early Breast Cancer
Oncologist
Cancer Research
Medicine
Oncology
RNA Chimeras as a Gene Signature of Breast Cancer
Identification of a Robust Gene Signature That Predicts Breast Cancer Outcome in Independent Data Sets
BMC Cancer
Cancer Research
Oncology
Genetics
Gene Signature: A Guideline for Hormonal Therapy in Breast Cancer
Journal of Steroids & Hormonal Science
Immortalization-Associated Gene Signature in Breast Cancer
Breast Cancer Research
Cancer Research
Oncology
The Predictive Value of the 70-Gene Signature for Adjuvant Chemotherapy in Early Breast Cancer
Breast Cancer Research and Treatment
Cancer Research
Oncology
The 21-Gene Recurrence Score Assay for Node-Positive, Early-Stage Breast Cancer and Impact of RxPONDER Trial on Chemotherapy Decision-Making: Have Clinicians Already Decided?
Journal of the National Comprehensive Cancer Network : JNCCN
Medicine
Oncology
2055 Effect of Delay in Initiating Radiotherapy for Patients With Early Stage Breast Cancer: Results of a Natural Experiment
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
A Study of the Impact of Data Sharing on Article Citations Using Journal Policies as a Natural Experiment
PLoS ONE
Multidisciplinary
